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Abstract
Bacteriocins are peptide-derived molecules produced by bacteria, whose
recently-discovered functions include virulence factors and signaling molecules as
well as their better known roles as antibiotics. To date, close to five hundred
bacteriocins have been identified and classified. Recent discoveries have shown
that bacteriocins are highly diverse and widely distributed among bacterial
species. Given the heterogeneity of bacteriocin compounds, many tools struggle
with identifying novel bacteriocins due to their vast sequence and structural
diversity. Many bacteriocins undergo post-translational processing or
modifications necessary for the biosynthesis of the final mature form. Enzymatic
modification of bacteriocins as well as their export is achieved by proteins whose
genes are often located in a discrete gene cluster proximal to the bacteriocin
precursor gene, referred to as context genes in this study. Although bacteriocins
themselves are structurally diverse, context genes have been shown to be largely
conserved across unrelated species. Using this knowledge, we set out to identify
new candidates for context genes which may clarify how bacteriocins are
synthesized, and identify new candidates for bacteriocins that bear no sequence
similarity to known toxins. To achieve these goals, we have developed a software
tool, Bacteriocin Operon and gene block Associator (BOA) that can identify
homologous bacteriocin associated gene clusters and predict novel ones. We
discover that several phyla have a strong preference for bactericon genes,
suggesting distinct functions for this group of molecules. Availability:
https://github.com/idoerg/BOA
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Background
Natural Product discovery has been a cornerstone of many pharmaceuticals and
therapeutics. It is estimated that about 80% of all drugs are either natural products
or derived analogs[1]. These compounds encompass antibiotics (penicillin, tetracy-
cline, erythromycin), anti-infectives (avermectin, quinine, artemisinin), pharmaceu-
ticals (lovastatin, cyclosporine, rapamycin) and anticancer drugs (taxol, doxoru-
bicin) [2]. Yet, despite this long history of success, pharmaceutical efforts in natu-
ral products research has decreased steadily between 2001 and 2008 [3]. Financial
pressure from drug companies as well as difficulties in isolation and identification
of natural compounds have severely limited the discovery rate of these important
sources.
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Bacteriocins are a large class of peptide-based antibiotics that encompass an ex-
traordinary amount of chemical, structural, and functional diversity[4]. The struc-
tures of these compounds have revealed that a large number comprise a class of
highly modified polypeptides. Interestingly, many bacteriocins are synthesized ri-
bosomally as precursor peptides and are subsequently modified post-translationally
to yield their biologically active forms. Post-translational modification serves to
confer specific chemical properties that could not be obtained by peptide synthesis
alone. Furthermore, post-translational modifications can be used as a mechanism
to control the activation of the toxic activities of the bacteriocin, and thus exert a
level of control and host immunity[5].
Genome mining has been an important technological resource in the discovery of
novel natural products, including bacteriocins. Bacteriocin-like peptides are highly
attractive candidates for genome mining, as these natural products are genetically
encoded with nearby genes encoding their corresponding modifying enzymes. Prox-
imity to genes encoding known modifying enzymes can often aid in the identification
of peptide biosynthesis gene clusters [6]. In many cases, several metabolites have
been identified from “cryptic” or “orphan gene clusters” [7]. These cryptic gene
clusters have demonstrated that new, as yet uncharacterized enzymology is likely
to be involved in the assembly of the final natural product, likely leading to a greater
diversity of bacterial peptides than previously appreciated.
Several web-based gene mining and annotation tools have been developed to
aid in the identification, characterization, and classification of novel bacteriocins.
These include mining tools such as BAGEL[8] and bacteriocin repositories such as
BACTIBASE[9]. Anti-SMASH is a recently developed website that expands genome
mining to not only bacteriocins but a host of other genetically-identifiable antibi-
otics and other secondary metabolites[10] Although gene mining resources such
as BAGEL have existed for many years, one major limitation in bacteriocin gene
mining that is becoming evident as more bacteriocins are identified is the lack of
homology in the genes encoding the actual precursor peptides for bacteriocins. De-
tecting novel bacteriocin producing genes through bioinformatic methods focused
on precursor peptide discovery therefore remains a significant challenge.
The bacteriocins’ structure and sequence diversity make them difficult to detect
using sequence homology algorithms such as BLAST[11]. In addition, their short
sequence length makes them difficult to detect with ORF calling tools. Programs
such as BAGEL have made great strides in identifying bacteriocins by searching for
well-defined conserved motifs within the bacteriocin toxin sequences and adjacent
context genes using Pfam databases[8]. However, the number of hypothetical bac-
teriocin genes that can be identified using such a method is highly limiting as these
motifs are not necessarily known or conserved. Given that bacteriocin genes are
highly diverse, it is likely that mining genomes for potential bacteriocin genes using
sequence or profile similarity are likely to miss a large number of as-yet identified
bacteriocin compounds.
Genes that encode bacteriocin precursors are often proximal in genomic sequence
to accessory genes that are required to modify and secrete the bacteriocin pep-
tide. These co-located gene blocks often contain genes that encode enzymes which
perform post-translational modification and maturation of the bacteriocin product.
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Additionally, many of these gene blocks contain genes encoding various transporter
proteins, presumably linked to specific export of the mature bacteriocin. Unlike the
bacteriocin genes, these context genes are conserved across taxa, as they belong to
conserved families of enzymes and other modifying proteins, as well as to trans-
porters such as ATP-binding cassette (ABC) family of transporters. In the case of
the large family of thiazole and oxazole modified bacteriocins, such as Microcin B17
and Streptolysin S, each gene block shares both conserved modification proteins as
well as transport machinery genes that are located close to the bacteriocin gene
[6, 12].
Here we present a new methodology that takes advantage of the conservation of
context genes to identify locations of gene blocks associated with bacteriocins. Our
approach is to identify context genes in addition to toxin genes without restricting
our tool to finding homologs in annotated databases. To the best of our knowledge,
there is no available public database that contains the complete bacteriocin gene
clusters and their associated context genes. Therefore, BOA is useful for the con-
struction of such a tool as well as for mining genomes for putative bacteriocins. We
provide bacteriocin gene block predictions for 2773 genomes, in which the bacteri-
ocin gene blocks may be browsed. The method is implemented as a software tool
named Bacteriocin Operon and gene block Associator (BOA)
Methods
We used the bacterial and archaeal genome files from GenBank 2014[13] for our
dataset. Since we are interested in identifying bacteriocin associated gene clusters,
we did not analyze partial contig files, and only whole bacterial chromosomes and
plasmids were analyzed. Bacteriocins identified by BAGEL3 and seven experimen-
tally identified bacteriocin associated gene blocks were used as a standard of truth
or a “gold standard” data set. All of the context genes within these gene blocks were
placed into five functional categories toxins, modifiers, immunity, transport, and
regulation. Toxin genes refer to the open reading frames encoding the toxin precur-
sor peptide; modifiers perform post-translational modification to the protoxin, and
can include enzymes which are involved in amino acid modification (cyclodehydra-
tion, lanthionine synthesis, as well as leader peptide processing enzymes); immunity
genes that prevent the toxin from affecting the host bacterial cells; transport genes
create transporter proteins to move the toxin outside of the cell, and regulator genes
control the expression of toxin proteins and other genes in the operon [6].
An overview of the pipeline is shown in Figure 1. The method in detail is as
follows:
1 Construct a set of experimentally-verified context genes. This we call the Lit-
erature Curated Set. The LC Set includes seven known bacteriocin associated
gene blocks. The known gene blocks comprised enterococcal cytolysin and en-
terocin AS-48 from Enterococcus faecalis, microcin J25 from Escherichia coli,
Nisin A from Lactococcus lactis subsp. lactis, streptolysin S and salivaricin
A from Streptococcus pyogenes, and thiocillin from Bacillus cereus [14–20].
These blocks are representative of several important classes of bacteriocins,
namely lantibiotics (enterococcal cytolysin, Nisin A, salivaricin A), thiopep-
tides (thiocillin), thiazole/oxazole-modified microcins (TOMMs; streptolysin
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S), lassoed tail peptides (microcin J25), and circular bacteriocins (enterocin
AS-48). While bacteriocin biosynthetic gene blocks are widely distributed
among prokarya, the major structurally-related groups are few and their rele-
vant context genes are largely represented in the LC Set. The genes were cat-
egorized as toxins, modifiers, immunity, transport, or regulation. The genes
making up the LC Set are available in the Supplementary Material.
2 BLAST the LC Set genes and the BAGEL toxin genes against the bacterial
genome set.
3 Select ORFs with (a) e-value < 10−5 and (b) within ± 50kb of the homologs
to the toxin genes (whether from the LC set or the BAGEL set).
4 Assign each homologous ORF according to the category of the gene to which
it is found to be similar: toxin, modifier, immunity, transport, or regulation.
Ambiguities are resolved by taking the best hit based on the BLAST score.
5 Build profile HMMs: cluster the sequences in each bin independently using
CD-HIT [21], then use MAFFT [22] to perform a multiple alignment in each
homology cluster, and HMMER [23] to build pHMMs from the multiple
alignments.
6 Run the resulting pHMM’s against the bacterial genome files. Since most of
the HMMER hits are probably false positives, we set a score threshold to filter
them out. We determined this threshold by obtaining HMMER scores for all
of the BAGEL bacteriocins found on the bacterial genomes and choosing the
lowest BAGEL score as the threshold. See Figure 2
7 Use a clique filter (see below) to identify those genes that are close together
and therefore candidates for bacteriocin gene blocks. See Figure 3.
To identify gene blocks that are candidates for bacteriocin biosynthesis, we used
a clique filter. A clique is a complete subgraph where any two nodes are connected
by an edge. We created graphs from the ±50kb regions where genes are represented
by nodes and for every pair of genes that are within 25kb of each other, an edge is
created between them. The detected cliques are estimated gene blocks such that all
of the genes are within 25kb of each other. This 25kb threshold was based on the
size of known bacteriocin gene clusters given in our gold standard data set. Figure 3
illustrates the use of the clique filter to identify potential bacteriocin gene blocks.
A major challenge in finding toxin genes is that due to the short length and low
complexity of these peptides, many genes will be missed because of ORF calling
errors or lack of similarity to known toxin genes. To overcome this problem, we
organized all detected cliques into gene blocks with homologs to known toxin genes
and gene blocks without known toxin genes. Cliques with known toxin genes are
required to have at least one toxin gene and one transport gene. Cliques without any
known toxin genes are required to have at least one of each of a modifier, transport,
immunity, and regulator genes. In this way, we ensure that the cliques we identify
have the needed components to present a putative bacteriocin biosynthetic locus,
and the toxin gene can later be searched using less restrictive procedures.
Results
The many characterized bacteriocins have seldom been experimentally validated
in parallel in the multiple species which putatively code for their production, re-
stricting our standard-of-truth data set to a small group of well-studied bacteriocins
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relative to the large number of organisms that produce them. In addition, estimating
the false positive rate is difficult, requiring excessive de novo experimental valida-
tion. Therefore, to evaluate BOA’s performance, we compared the bacteriocins that
we have found to BAGEL bacteriocins found in bacterial genomes.
To compare BOA against BAGEL, the toxins shared between BOA and BAGEL
were identified using BLAST using the default parameters. As shown in Table 1,
BOA only missed 22 (5%) bacteriocins that BAGEL detected, while predicting
457 (95%) in agreement with BAGEL. In addition, BOA was able to predict over
1003 more putative bacteriocins on bacterial genomes than BAGEL. In addition,
BOA identified 83 regions that are highly likely to be associated with bacteriocin
production.
The detected gene blocks were classified into five groups: (1) gene blocks with
all five functional classes (toxin, modifier, immunity, regulator, transport), (2) gene
blocks with only four functions, (3) three functions, (4) two functions, and (5)
unknown toxins. Figure 5 shows these findings.
Previously it has been established that every bacteriocin locus needs at minimum
a toxin gene and an immunity gene[24]. The gene blocks in the first four groups in
Figure 4 and Figure 5b all have at least one toxin and one transport gene. The final
group of gene blocks do not have any identified bacteriocin genes, but each detected
gene block is required to have all of the other genes. This final group contains likely
candidates for bacteriocin-associated gene blocks that do not yet have a known,
identified bacteriocin. From these findings, it is evident that genes categorized as
transport genes were identified to be the most common type of context gene.
Interestingly, the three species harboring the greatest number of predicted
bacteriocin-associated gene blocks in our screen inhabit different ecological niches.
Streptococcus equi subsp. zooepidemicus is a common colonizer of the respiratory
tract with the capacity for opportunistic infection in a variety of domesticated
animals and sometimes severe infections in humans following zoonotic transmis-
sion [25]. Streptomyces griseus is a soil-dwelling bacterium that has been studied
and utilized in the biotechnology industry for production of numerous secondary
metabolites including the first aminoglycoside antibiotic, streptomycin [26]. Finally,
Leifsonia xyli is a pathogenic obligate colonizer of the xylem of host plants, caus-
ing economically damaging ratoon stunting disease in sugarcane [27]. The radically
different environments in which these bacteria reside suggest that predicted bacte-
riocins must have distinct functions, specific organism targets, or both. Likewise,
functional validation and characterization of these kinds of predicted bacteriocins
must take into account the niche in which its producing organism resides, probing
functionalities that target ecologically relevant target organisms.
Among the gene blocks identified by BOA was the recently described and ex-
perimentally characterized caynothecamide biosynthetic locus of Cyanothece sp.
PCC 7425 (GenBank: CP001344.1) [28]. This gene block, part of the patellamide
family, has nine predicted precursor peptide ORFs with conserved N-termini and
divergent C-termini likely resulting from repeated precursor duplication and di-
vergence. Other bacteriocin clusters have been described with only one precursor
peptide duplication, and such examples may represent an early step toward the
substrate elaboration displayed by the cyanothecamides [29]. Interestingly, most of
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the cyanothecamide putative precursors lack the canonical pentapeptide motif re-
quired for patellamide maturation, suggesting that inclusion of these sequences in
the BOA gold standard set could expand the set of identified putative toxin genes
to include other non-canonical substrates. Only two of the nine cyanothecamide pu-
tative toxin genes have been experimentally implicated as precursors to identifiable
mature patellamide-like compounds [30]. Yet, the capacity for biosynthetic machin-
ery to modify substrate peptides with suitable N-terminal domains despite drastic
variability in the C-terminal portion of the peptide has been demonstrated in other
bacteriocins [31, 32]. The features of this particular gene block raise the possibility
that bacteriocin loci encoding post-translationally modified peptides could, through
elaboration of sequence diversity in multiple cognate peptide substrates, confer a
greater breadth of functional diversity to producing organisms than previously ap-
preciated [33].
Within the genome of the important human pathogen Group A Streptococcus
from which two members of our gold standard set were obtained (Streptolysin S
and Salivaricin A), BOA also identified the gallidermin-related lantibiotic Streptin
[34]. Despite the experimental validation of Streptin as an active bacteriocin, little
further insight has been gained into the role of Streptin with respect to pathogenic
infection or colonization dynamics [35]. Identification and subsequent experimental
validation of bacteriocins in important human pathogens like Group A Streptococcus
will likely yield insights into the biology and biochemistry of pathogenic coloniza-
tion, especially given the current explosion of interest in the human microbiome
and probiotic disease interventions.
Of the 1054 species with identified bacteriocins, only 11 species were from the
domain Archaea out of 360 Archaea genomes in GenBank. From the 1043 bacterial
species with bacteriocins identified, the majority of them are identified as either
Proteobacteria or Firmicutes. The exact breakdown of the phyla and their corre-
sponding mean function counts is shown in Table 3. It is important to note that
our finding does not imply that most bacteriocin producing bacteria are Firmicutes
and Proteobacteria, or that bacteriocins are rare in Archaea. It is more likely that
previous research in identifying bacteriocins was biased towards the former two
phyla.
From Table 3, it is apparent that mean distribution of gene types between phyla
are very different. For instance, Firmicutes have significantly more immunity genes
than any of the other phyla. Also, gene blocks found in Firmicutes, Actinobacteria
and Cyanobacteria have a higher toxin gene count than other bacterial phyla.
Conclusions
To our knowledge, BOA is the first time a curated data set has been established
for bacteriocin context genes. Even with seven different bacteriocin gene blocks as
a gold standard set, our method has identified several hundred putative bacteriocin
gene blocks, most of which have not been previously annotated. We believe that
even more homologous gene blocks can be identified with a larger validated database
of context genes. Additionally, upon manual inspection of some predicted blocks,
some nearby putative ORFs appeared likely to be involved in predicted bacteriocin
biosynthesis but were not identified by BOA. This may permit a manually curated
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strategy whereby one may subjectively designate putative context genes from a
BOA-predicted bacteriocin gene block and feed the more richly-annotated gene
block back into BOA as a new member of the now-expanded gold standard set.
Such an approach could serve to iteratively extend the phylogenetic boundaries of
BOA in a controlled way each time the limits of similarity are reached. We are
currently exploring the merits of this approach. The widespread prevalence and
diversity of bacteria having bacteriocins and their highly varied lifestyles suggest
early ancestry and a subsequent adaptation of these gene blocks to the specific
functional needs of the bacteria producing them. Previous studies have shown that
bacteriocin context genes tend to be in bacteria that share an environmental niche
despite phylogenetic disparity, suggesting that functional adaptation is likely to be
a major mechanism for bacteriocin design and production [12].
BOA was able to identify the majority of bacteriocin gene clusters that BAGEL
identified. BOA also predicted over seven times more bacteriocins in whole bacterial
genomes than BAGEL, including many identifiable bacteriocin gene blocks with
experimental validation. Because BOA encompasses a large number of taxa, the
information in BOA can also be used to explore the evolutionary development of
bacteriocin gene blocks and how different biosynthetic loci have evolved in different
clades. Finally, BOA has assembled the first dataset that contains information about
homologous bacteriocin genes and their associated gene clusters.
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Figures
Figure 1: An overview of the BOA Pipeline. The stages in the pipeline are elaborated upon
in the Methods section. (1): construction of the LC-Set and the BAGEL set; (2) BLAST LC and
BAGEL genes against all bacterial & archaeal genomes evalue=10−5; (3) select the ORFs within
±50kb of homologs to toxin genes (4) assign ORFs to one of the following classes (left to right):
toxin, modifier, immunity, transport, regulation; (5) build pHMMs from each category: cluster
sequences using CD-HIT, align sequences in each cluster using MAFFT, then use hmmbuild from
the HMMER suite to construct HMMs; (6) run hmmsearch from the HMMER suite against the
genome files to extract more sequences from each category, remove predicted false positives using
a threshold score as explained in Methods (7) use a clique filter to identify genes that are close
together.
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Figure 2: Determining the threshold for similarity-based search of toxin genes. Toxin
gene candidates were derived as described in the text. To determine an adequate threshold for
inferring homology, we examined the distribution of HMMER scores for homologs for predicted
toxin genes (red) and BAGEL-derived toxin genes (blue). BAGEL toxin gene scores were used to
set a minimum threshold of acceptance for HMMER scores for predicted genes.
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Figure 3: Using a clique filter to identify putative bacteriocin gene blocks. Drawing is
not to scale, and other genes may exist in between those shown. A, B and C are all cliques formed
from these genes. Clique A has an identifiable homolog to a known toxin, and is considered a viable
candidate for a toxin gene block. Clique B does not have all necessary functions, and therefore is not
considered to be a candidate. Clique C contains all necessary functions and therefore is considered
a candidate for a bacteriocin gene block or operon even though there is no homology-detected
toxin gene.
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Figure 4: 95% (457 out of 479) of BAGEL toxins were predicted by BOA. BOA predicted an
additional 1003 toxins throughout bacterial genomes that are not listed in BAGEL. Twenty-two
BAGEL toxins were not predicted by BOA.
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(a) Gene counts
(b) Gene counts per gene block
Figure 5: Gene blocks were classified by the number of detected functions. (a): number of total
genes found; (b) gene counts per detected block.
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Figure 6: A tree of all of the species with detected bacteriocins. The five inner rings show gene
abundances for immunity, modifier, regulator, toxin and transport genes. The outer ring shows
the total number of bacteriocin-associated gene blocks detected for each bacterial species. This
information is available in tabular form in the Supplementary Material.
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Tables
Item Quantity
BAGEL Toxins 479
Gene blocks predicted by BOA with toxin genes 1,003
Gene blocks predicted by BOA without toxin genes 83
Table 1: Number of gene blocks detected by BAGEL and BOA.
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Name Genbank ID # Gene Blocks Immunity Modifier Regulator Toxin Transport
Streptococcus equi subsp.
zooepidemicus MGCS10565
CP001129.1 6 6 8 0 9 11
Streptomyces griseus subsp.
griseus NBRC 13350
AP009493.1 6 0 0 0 8 14
Leifsonia xyli subsp. xyli str.
CTCB07
AE016822.1 5 0 0 0 7 8
Pusillimonas sp. T7-7 CP002663.1 4 1 0 0 6 8
Rhodospirillum rubrum F11 CP003046.1 4 0 0 0 4 4
Streptococcus salivarius
CCHSS3
FR873481.1 4 5 1 0 4 5
Streptomyces sp. PAMC26508 CP003990.1 4 0 0 0 4 4
Streptomyces pratensis ATCC
33331
CP002475.1 4 0 0 0 4 5
Symbiobacterium thermophilum
IAM 14863
AP006840.1 4 0 0 1 4 5
Thermotoga neapolitana DSM
4359
CP000916.1 4 5 0 3 4 6
Table 2: Bacterial species with the highest number of BOA-detected gene blocks
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Phylum Immunity Modifier Regulator Toxin Transport # Genomes
Thermotogae 0.8 0 0.2 1.4 1.8 5
Proteobacteria 0.17 0.05 0.03 1.29 1.47 512
Cyanobacteria 0.13 0.13 0.0968 1.806 1.548 31
Deinococcus-Thermus 0 0 0.333 2 2.667 8
Euryarchaeota 0.5 0 0 0.75 1 6
Actinobacteria 0.337 0.045 0.067 1.708 2.168 89
Spirochaetes 0.06 0.06 0 1.151 1.424 33
Crenarchaeota 1 0 0 1 1 5
Firmicutes 1.182 0.578 0.399 1.594 2.059 318
Bacteroidetes 0.12 0 0 1.24 1.28 25
Table 3: Mean counts per gene block over all phyla that have more than 5 genomes
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Class Immunity Modifier Regulator Toxin Transport # Genomes
Spirochaetales 0.06 0.06 0 1.15 1.42 33
Actinobacteridae 0.32 0.05 0.07 1.72 2.17 86
Gammaproteobacteria 0.21 0.04 0.04 1.31 1.58 244
Epsilonproteobacteria 0.19 0 0.05 1.09 1.05 21
Bacilli 1.25 0.77 0.48 1.62 2.15 232
Betaproteobacteria 0.07 0.09 0.05 1.41 1.56 114
Clostridia 1 0.06 0.19 1.53 1.82 84
Alphaproteobacteria 0.16 0.045 0.02 1.18 1.22 110
Oscillatoriophycideae 0.09 0.14 0.09 1.90 1.54 22
Table 4: Mean counts per gene block over all classes that have more than 10
genomes
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Additional Files
Files are zipped into sup materials.zip
00README.txt
the following list.
bagel unique.csv
The toxins in the BAGEL database that haven’t been identified by BOA. BAGEL ID’s literature reference, GenBank
cross reference, and protein sequence.
functions.txt
Per-species counts for each functional ortholog in identified bacteriocin gene blocks.
map.txt
A mapping from GenBank ids to gene functions for the detected gene blocks.
gene blocks.fa
The protein sequences of all of the detected gene blocks, their predicted functions and the gene block each protein
is in.
lc set.txt
Details the literature curated dataset
lc seqs.tgz
Sequence files of the lc set genes.
predicted gene blocks.fa
The protein sequences of all of the detected gene blocks without toxin genes, their predicted functions and the gene
block each protein is in.
